The Role of Noncontrast Computed Tomography Markers in Predicting the Clinical Outcome of Cerebral Hemorrhage
NCT ID: NCT06535438
Last Updated: 2024-08-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
1000 participants
OBSERVATIONAL
2024-08-01
2024-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main question it aims to answer is:How to judge the prognosis of patients with cerebral hemorrhage by CT image reading at admission.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Research on the Clinical Value of Cranial CT and CTA for Cerebral Hemorrhage Patients
NCT07100132
Predictors of Early Hematoma Expansion in Patients With Acute Intracerebral Hemorrhage (Clinical and Laboratory Study)
NCT06490978
Clinical Diagnosis and Treatment of Intracerebral Hemorrhage Based on Artificial Intelligence
NCT04951570
Assessment of Intracerebral Hematoma
NCT05158660
Retrospective Study on the Direction of Artificial Intelligence in Identifying Cranial Trauma CT Imaging
NCT06230419
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
The prognosis of cerebral hemorrhage is good at 90 days
No interventions assigned to this group
The prognosis of cerebral hemorrhage is poor at 90 days
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. had completed a CT examination within 24 h of disease onset;
3. had a hemorrhage that was located in the brain parenchyma, including the basal ganglia, thalamus,brain lobes, brainstem, and cerebellum.
Exclusion Criteria
2. had ischemic cerebral infarction hemorrhagic transformation;
3. had undergone surgical treatment (e.g.hematoma removal or puncture drainage) before the CT examination;
4. had images of poor quality that could notbe accurately evaluated;
5. had a hematoma withborders that could not be delineated, thus precluding delineation of the region of interest (ROI).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jin Hu
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jin Hu
Huashan Hospital, Fudan University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FDHS2024
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.